Clinical Effect of Reflexology and Homeopathy Added to Conventional Asthma Management
Effect of Reflexology, Homeopathy and Conventional Medical Treatment in Asthma: A Randomised Controlled, Parallel Group Trial.
1 other identifier
interventional
98
1 country
1
Brief Summary
There is a lack of scientific evidence that homeopathy and reflexology is effective treatment of asthma. Systematic reviews have found that many clinical trials testing homeopathy and reflexology have major flaws, such as small number of participants, lack of control groups or inadequate allocation concealment. The aim of the present study was to assess the effect of reflexology and individualised homeopathy as an adjuvant treatment in asthma. In order to address this issue, the investigators conducted an investigator-blinded, randomized, controlled parallel group study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable asthma
Started May 2006
Typical duration for not_applicable asthma
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2009
CompletedFirst Submitted
Initial submission to the registry
August 18, 2011
CompletedFirst Posted
Study publicly available on registry
August 30, 2011
CompletedAugust 30, 2011
August 1, 2011
3.4 years
August 18, 2011
August 29, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The change in the Asthma Quality of Life Questionnaire(AQLQ)
AQLQ is self-administered questionnaire which consists of 32 questions in 4 domains (symptoms, activity limitation, emotional function and environmental stimuli). Patients responded to each question on a seven point scale (7=no impairment 1=maximal impairment) and recalled their experiences during the previous 2 weeks. The overall AQLQ score was the mean of all 32 questions. A change in score of ≥0.5 indicates the minimal important difference (MID) in AQLQ.
Assesment of quality of life was perfomed at baseline, at week 26 and at week 52.
Secondary Outcomes (11)
Asthma control questionnaire (ACQ)
At baseline, week 26 and week 52
EuroQol(EQ-5D)
At baseline, week 26 and week 52
Forced expiratory volume in 1 second
At baseline, week 26 and week 52
Asthma symptoms
Two weeks prior to week 2, 26 and 52.
Peak expiratory flow
Two weeks prior to week 2, 26 and 52.
- +6 more secondary outcomes
Study Arms (3)
Reflexology plus conventional treatment
EXPERIMENTALHomeopathy plus conventional treatment
EXPERIMENTALConventional treatment
NO INTERVENTIONInterventions
Patients in the reflexology group received reflexology treatment in addition to usual care of asthma.Patients received treatments weekly for four to six weeks, followed by two treatments for one month. Treatments were then given monthly until the end of the study.
Patients in the homeopathy group received homeopathic treatment in addition to usual care of asthma.Homeopathic treatment was decided on an individual basis by the homeopath and prescribed as an oral treatment. Patients received homeopathic product with potency between C30 (dilution by a factor 10030 =1060) and M10 (dilution by a factor 100010 =1030). The number of homeopathy sessions attended was six to twelve during one year.
Patients in the conventional treatment group received usual care of asthma. This treatment was monitored and adjusted as usual by the patient's general practitioner.
Eligibility Criteria
You may qualify if:
- Forced expiratory volume in 1 second (FEV1) ≥60% predicted
- A history of bronchial asthma for minimum 6 months prior to baseline
- An objective measure of abnormal variation in bronchial calibre(The objective measure were defined as at least one of the following)
- a positive bronchodilator reversibility test, defined as increase in FEV1≥10% after 400 µg inhaled salbutamol;
- a positive methacholine test, defined as a PD20 of \<1000 μg;
- a positive test for exercise induced asthma defined as a fall in FEV1\>15% after a standardised 6 min exercise test; and
- a positive peak expiratory flow (PEF) variability , defined by ≥3 days or 2 consecutive days with a differences between morning and evening PEF of \>20% during a 2-week period.
You may not qualify if:
- Hospitalization for asthma within 3 months,
- Asthma exacerbation during the last month,
- Changes in asthma medication within 30 days of screening
- A smoking history \> 10 pack-years and smoking within the last year.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Aarhuslead
- GCP-unit at Aarhus University Hospital, Aarhus, Denmarkcollaborator
- Danish Classical Homeopathy Societycollaborator
- Danish Reflexologist Associationcollaborator
Study Sites (1)
Department of Respiratory Diseases, University Hospital of Aarhus
Aarhus, 8000, Denmark
Related Publications (7)
Ng TP, Wong ML, Hong CY, Koh KT, Goh LG. The use of complementary and alternative medicine by asthma patients. QJM. 2003 Oct;96(10):747-54. doi: 10.1093/qjmed/hcg121.
PMID: 14500861BACKGROUNDJonas WB, Kaptchuk TJ, Linde K. A critical overview of homeopathy. Ann Intern Med. 2003 Mar 4;138(5):393-9. doi: 10.7326/0003-4819-138-5-200303040-00009.
PMID: 12614092BACKGROUNDMcCarney RW, Linde K, Lasserson TJ. Homeopathy for chronic asthma. Cochrane Database Syst Rev. 2004;2004(1):CD000353. doi: 10.1002/14651858.CD000353.pub2.
PMID: 14973954BACKGROUNDErnst E. Is reflexology an effective intervention? A systematic review of randomised controlled trials. Med J Aust. 2009 Sep 7;191(5):263-6. doi: 10.5694/j.1326-5377.2009.tb02780.x.
PMID: 19740047BACKGROUNDBrygge T, Heinig JH, Collins P, Ronborg S, Gehrchen PM, Hilden J, Heegaard S, Poulsen LK. Reflexology and bronchial asthma. Respir Med. 2001 Mar;95(3):173-9. doi: 10.1053/rmed.2000.0975.
PMID: 11266233BACKGROUNDLewith GT, Watkins AD, Hyland ME, Shaw S, Broomfield JA, Dolan G, Holgate ST. Use of ultramolecular potencies of allergen to treat asthmatic people allergic to house dust mite: double blind randomised controlled clinical trial. BMJ. 2002 Mar 2;324(7336):520. doi: 10.1136/bmj.324.7336.520.
PMID: 11872551BACKGROUNDWhite A, Slade P, Hunt C, Hart A, Ernst E. Individualised homeopathy as an adjunct in the treatment of childhood asthma: a randomised placebo controlled trial. Thorax. 2003 Apr;58(4):317-21. doi: 10.1136/thorax.58.4.317.
PMID: 12668794BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ronald Dahl, MD
Department of Respiratory Diseases, University Hospital of Aarhus, DK-8000 Aarhus C
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D.
Study Record Dates
First Submitted
August 18, 2011
First Posted
August 30, 2011
Study Start
May 1, 2006
Primary Completion
October 1, 2009
Study Completion
October 1, 2009
Last Updated
August 30, 2011
Record last verified: 2011-08